Baxter Homechoice

Designed to enhance APD therapy from the inside out

The Homechoice Claria system represents the next generation in Homechoice, the world’s most widely prescribed APD cycler and the established market leader in 97 countries1. The Homechoice Claria APD system features the Sharesource connectivity platform, which facilitates on-demand access to precise patient data, allowing you to proactively manage patients remotely and make timely therapy decisions.

Categories: , ,


Patients treated with PD have better early survival than those treated with conventional hemodialysis:

  • PD may help avoid vascular access and associated morbidity
  • Designed for a smoother lifestyle transition compared to
    conventional hemodialysis.
  • Flexibility to travel


There are no reviews yet.

Be the first to review “Baxter Homechoice”

Your email address will not be published.